X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Prism Medico and Pharmacy Ltd.
BSE CODE: 512217   |   NSE CODE: NA   |   ISIN CODE : INE730E01016   |   03-Feb-2025 Hrs IST
BSE NSE
Rs. 15.98
-0.02 ( -0.12% )
 
Prev Close ( Rs.)
16.00
Open ( Rs.)
16.30
 
High ( Rs.)
16.30
Low ( Rs.)
15.32
 
Volume
15485
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.04  -0.13  -0.61  -0.21  -0.08  
   CEPS(Rs)-0.03  -0.11  -0.60  -0.19  -0.05  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)24.97  25.01  20.71  21.32  21.53  
   Tax Rate(%)23.57  25.34  25.86  25.80  26.22  
Margin Ratios          
   Core EBITDA Margin(%)-4.71  -7.63  -5.80  -0.97  -0.19  
   EBIT Margin(%)-0.71  -8.02  -5.90  -1.04  -0.25  
   Pre Tax Margin(%)-0.96  -8.04  -5.91  -1.05  -0.25  
   PAT Margin (%)-0.73  -6.00  -4.38  -0.78  -0.19  
   Cash Profit Margin (%)-0.55  -5.49  -4.28  -0.70  -0.12  
Performance Ratios          
   ROA(%)-0.14  -0.55  -2.18  -0.60  -0.26  
   ROE(%)-0.14  -0.55  -2.90  -1.00  -0.38  
   ROCE(%)-0.14  -0.74  -3.91  -1.35  -0.52  
   Asset Turnover(x)0.19  0.09  0.50  0.78  1.40  
   Sales/Fixed Asset(x)80.81  30.17  63.64  76.22  122.27  
   Working Capital/Sales(x)0.20  0.09  0.69  1.54  2.44  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.01  0.03  0.02  0.01  0.01  
   Receivable days527.23  1384.74  397.56  346.74  149.95  
   Inventory Days844.82  1944.81  251.09  53.28  6.85  
   Payable days2.20  0.00  178.61  184.95  82.41  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-1027.39  -249.06  -12.79  -60.06  -231.30  
   Price/Book(x)1.09  1.14  0.37  0.55  0.58  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)5.63  13.59  0.54  0.42  0.28  
   EV/Core EBITDA(x)-1054.96  -181.15  -9.32  -42.94  -148.01  
   EV/EBIT(x)-787.43  -169.42  -9.16  -39.89  -109.58  
   EV/CE(x)1.09  1.14  0.37  0.32  0.34  
   M Cap / Sales5.65  13.66  0.55  0.42  0.28  
Growth Ratio          
   Net Sales Growth(%)130.20  -84.95  -49.63  -37.66  -25.93  
   Core EBITDA Growth(%)83.63  80.54  -201.30  -223.51  -115.70  
   EBIT Growth(%)79.49  79.56  -184.90  -157.80  -123.13  
   PAT Growth(%)71.95  79.37  -184.50  -158.70  -113.60  
   EPS Growth(%)71.95  79.37  -184.52  -158.68  -113.60  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)147.68  65.35  708.22  2.26  2.29  
   Quick Ratio(x)80.97  36.13  319.61  1.70  2.29  
   Interest Cover(x)-2.94  -339.67  -1083.14  -709.78  -272.12  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00